Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

A resource for large-scale RNA-interference-based screens in mammals.

Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S, Balija V, O'Shaughnessy A, Gnoj L, Scobie K, Chang K, Westbrook T, Cleary M, Sachidanandam R, McCombie WR, Elledge SJ, Hannon GJ.

Nature. 2004 Mar 25;428(6981):427-31.

PMID:
15042091
2.

[Application of RNAi library to oncology investigation].

Weng DH, Wang SX, Ma D.

Ai Zheng. 2008 Nov;27(11):1229-32. Review. Chinese.

PMID:
19000460
3.

Mammalian RNAi: a practical guide.

Sandy P, Ventura A, Jacks T.

Biotechniques. 2005 Aug;39(2):215-24. Review.

4.

Enzymatically prepared RNAi libraries.

Buchholz F, Kittler R, Slabicki M, Theis M.

Nat Methods. 2006 Sep;3(9):696-700. Review.

PMID:
16929314
5.

Lessons from Nature: microRNA-based shRNA libraries.

Chang K, Elledge SJ, Hannon GJ.

Nat Methods. 2006 Sep;3(9):707-14. Review.

PMID:
16929316
6.

RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age.

Silva J, Chang K, Hannon GJ, Rivas FV.

Oncogene. 2004 Nov 1;23(51):8401-9. Review.

PMID:
15517022
7.

Genome-wide application of RNAi to the discovery of potential drug targets.

Ito M, Kawano K, Miyagishi M, Taira K.

FEBS Lett. 2005 Oct 31;579(26):5988-95. Epub 2005 Aug 22. Review.

8.

Functional genomic analysis of cell division by endoribonuclease-prepared siRNAs.

Kittler R, Buchholz F.

Cell Cycle. 2005 Apr;4(4):564-7. Epub 2005 Apr 19. Review.

PMID:
15876870
9.

Genome-scale loss-of-function screening with a lentiviral RNAi library.

Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM.

Nat Methods. 2006 Sep;3(9):715-9. Review.

PMID:
16929317
10.

RNA interference: from gene silencing to gene-specific therapeutics.

Leung RK, Whittaker PA.

Pharmacol Ther. 2005 Aug;107(2):222-39. Review.

PMID:
15908010
11.

shRNA libraries and their use in cancer genetics.

Bernards R, Brummelkamp TR, Beijersbergen RL.

Nat Methods. 2006 Sep;3(9):701-6. Review.

PMID:
16929315
12.

RNA interference in mice.

Kühn R, Streif S, Wurst W.

Handb Exp Pharmacol. 2007;(178):149-76. Review.

PMID:
17203655
13.

RNA interference--significance and applications.

Stanisławska J, Olszewski WL.

Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):39-46. Review.

PMID:
15761375
14.

HIV-1-specific RNA interference.

Boden D, Pusch O, Ramratnam B.

Curr Opin Mol Ther. 2004 Aug;6(4):373-80. Review.

PMID:
15468596
15.
16.

Vector-based RNAi approaches for stable, inducible and genome-wide screens.

Fewell GD, Schmitt K.

Drug Discov Today. 2006 Nov;11(21-22):975-82. Epub 2006 Sep 26. Review.

PMID:
17055406
17.

Cellular phenotyping by RNAi.

Fuchs F, Boutros M.

Brief Funct Genomic Proteomic. 2006 Mar;5(1):52-6. Epub 2006 Feb 23. Review.

PMID:
16769679
18.

RNA-based drugs: from RNA interference to short interfering RNAs.

Poliseno L, Mercatanti A, Citti L, Rainaldi G.

Curr Pharm Biotechnol. 2004 Aug;5(4):361-8. Review.

PMID:
15320767
19.

Generation of hairpin-based RNAi vectors for biological and therapeutic application.

Boudreau RL, Davidson BL.

Methods Enzymol. 2012;507:275-96. doi: 10.1016/B978-0-12-386509-0.00014-4. Review.

PMID:
22365779
20.

Vectors for RNA interference.

Wadhwa R, Kaul SC, Miyagishi M, Taira K.

Curr Opin Mol Ther. 2004 Aug;6(4):367-72. Review.

PMID:
15468595

Supplemental Content

Support Center